首页> 外国专利> Use a set that contains (i) a container containing formoterol, a Salt or solvate, (ii) a container with the second ACTIVE AGENT, (iii) where the reason I: II is 1: 2.500 to 12: 1 and IV) administration instructions for preparing Medicine useful in the treatment of chronic obstructive pulmonary disease.

Use a set that contains (i) a container containing formoterol, a Salt or solvate, (ii) a container with the second ACTIVE AGENT, (iii) where the reason I: II is 1: 2.500 to 12: 1 and IV) administration instructions for preparing Medicine useful in the treatment of chronic obstructive pulmonary disease.

机译:使用一套包含(i)含有福莫特罗,盐或溶剂化物的容器,(ii)具有第二种活性剂的容器,(iii)原因I:II为1:2.500至12:1且IV)给药的套装制备说明可用于治疗慢性阻塞性肺疾病的药物。

摘要

Use of a composition comprising, Mixed or separately.That is a First Active Ingredient formoterol, a pharmaceutically acceptable Salt or solvate thereof, or a solvate of the sa B.A Second Active Ingredient is budesonide, and a molar ratio of the First Active Ingredient to the segundoingrediente Active 1: 2500 12: 1Serves for the preparation of a Medicament for use in the treatment of chronic obstructive pulmonary disease.
机译:包含,混合或分开的组合物的用途,所述组合物是第一活性成分福莫特罗,其药学上可接受的盐或溶剂化物或该盐的溶剂化物; B.第二种活性成分是布地奈德,第一种活性成分与segundoingrediente活性物质的摩尔比为1:2500 12:1,用于制备用于治疗慢性阻塞性肺疾病的药物。

著录项

  • 公开/公告号CL2001002744A1

    专利类型

  • 公开/公告日2002-10-02

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号CL2001002744

  • 发明设计人 BAUER CARL-AXEL TOFAST JAN;

    申请日2001-11-14

  • 分类号A61K31/165;A61K31/57;A61P11/00;

  • 国家 CL

  • 入库时间 2022-08-22 00:45:53

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号